BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3085750)

  • 41. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of [1-14C]-arachidonic acid by cultured calf aortic endothelial cells: evidence for the presence of a lipoxygenase pathway.
    Kühn H; Pönicke K; Halle W; Wiesner R; Schewe T; Förster W
    Prostaglandins Leukot Med; 1985 Mar; 17(3):291-303. PubMed ID: 3921988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of contaminating platelets in thromboxane synthesis in primary cultures of human umbilical vein endothelial cells.
    Pfister SL; Hughes MJ; Rosolowsky M; Campbell WB
    Prostaglandins Other Lipid Mediat; 2002 Sep; 70(1-2):39-49. PubMed ID: 12428677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eicosapentaenoic acid potentiates the production of prostacyclin-like material in the arachidonic acid perfused human umbilical vein.
    Kristensen SD; Arnfred T; Dyerberg J
    Thromb Res; 1984 Nov; 36(4):305-14. PubMed ID: 6098049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells.
    Eldor A; Polliack G; Vlodavsky I; Levy M
    Thromb Haemost; 1983 Apr; 49(2):132-7. PubMed ID: 6346571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester.
    Zavoico GB; Hrbolich JK; Gimbrone MA; Schafer AI
    J Cell Physiol; 1990 Jun; 143(3):596-605. PubMed ID: 2113537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phorbol esters and oleoyl acetoyl glycerol enhance release of arachidonic acid in platelets stimulated by Ca2+ ionophore A23187.
    Halenda SP; Zavoico GB; Feinstein MB
    J Biol Chem; 1985 Oct; 260(23):12484-91. PubMed ID: 3930496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The differences in 12-hydroxyeicosatetraenoic acid and thromboxane B2 release from guinea pig platelets.
    Mike I; Ichikawa Y; Shimizu T; Honda ZI; Seyama Y; Ishii A
    Prostaglandins; 1991 Nov; 42(5):431-40. PubMed ID: 1763200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.
    Zavoico GB; Ewenstein BM; Schafer AI; Pober JS
    J Immunol; 1989 Jun; 142(11):3993-9. PubMed ID: 2497185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
    Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arachidonic acid availability and prostacyclin production by cultured human endothelial cells.
    Spector AA; Kaduce TL; Hoak JC; Czervionke RL
    Arteriosclerosis; 1983; 3(4):323-31. PubMed ID: 6411051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of eicosanoids by deendothelialized rabbit aorta: interaction between platelets and vascular wall in the synthesis of prostacyclin.
    Papp AC; Crowe L; Pettigrew LC; Wu KK
    Thromb Res; 1986 May; 42(4):549-56. PubMed ID: 3520943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human platelet secreted proteins and prostacyclin production by bovine aortic endothelial cells.
    Poggi A; Niewiarowski S; Stewart GJ; Sobel E; Smith JB
    Proc Soc Exp Biol Med; 1983 Apr; 172(4):543-50. PubMed ID: 6221344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elucidation of a role of plasma albumin during collagen-induced aggregation of bovine platelets.
    Sekiya F; Takagi J; Saito Y
    Thromb Res; 1989 Nov; 56(3):407-15. PubMed ID: 2515611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of prostanoid synthesis in cultured human vascular endothelial cells derived from omentum and umbilical vein.
    Stansby G; Shukla N; Hamilton G; Jeremy J
    Eur J Vasc Surg; 1991 Oct; 5(5):501-6. PubMed ID: 1959679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of an assay for studying the effects of agents on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in washed human platelets.
    Dragan YP; Ellis EF
    Prostaglandins Leukot Essent Fatty Acids; 1990 Feb; 39(2):105-9. PubMed ID: 2111551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.